we believe that the list of agents previously considered first- and second-line medications for the overactive bladder needs to be revised. State-of-the-art treatment of OAB in 1999 includes ...

Frequent urination often signals underlying health conditions that require medical attention. While occasional increases in ...

An overactive bladder (OAB) causes a sudden and frequent urge to urinate, often leading to involuntary leakage. While conventional treatments such as medications, bladder training, and lifestyle ...

Bodies change as they age, especially after physically demanding experiences like pregnancy. Many of those changes don't have ...

Botox has been shown to be an effective treatment option for bladder problems. In studies, people who received Botox injections for overactive bladder (OAB) symptoms saw improvements in certain ...

There is a wide range of variability with how often one should pee, particularly in regard to what’s “normal.” Learn if you ...

One in six adults have bladder control problems. It can disrupt sleep or cause accidents, lead to social isolation and depression and affects women more than men.

Symptoms of a UTI may be similar to those of an overactive bladder (OAB). But UTI symptoms caused by bacteria in your bladder can worsen if you don’t get treatment. In some cases, untreated UTI ...

A recent groundbreaking study revealed that an amnion/chorion (AC) bilayer product could treat interstitial cystitis/bladder ...

"We are thrilled to have the support of leading investors and partners who share our vision of transforming overactive bladder treatment," remarked Avner Geva, CEO of Vensica. "This funding will ...

Jason Whiting, with more than 25 years' experience in medical technology, steps in as CEO of Avation Medical Inc. He succeeds co-founder Jill Schiaparelli, who led the company since 2018, starting ...

They may recommend treatments to help manage your symptoms ... are medications that doctors can prescribe to treat an overactive bladder (OAB). Some side effects have been reported in both ...